Heparin Sodium Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Heparin Sodium Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 11/14/2017. Reported reason: Other

Shortage Details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-519-77
Dosage Form
Injection
Presentation
Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77)
Initial Posting
11/14/2017
Revised Date

Reason

Other